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Autism spectrum disorders (ASDs) affect ~1% of the
population and are characterized by impairments in
social interaction and communication, as well as by repe-
titive and restricted behaviours. ASDs include mild to
severe levels of impairment, with cognitive function ran-
ging from above average to intellectual disability (ID),
and are often accompanied by seizures and other medical
problems. There is an ~4:1 male to female gender ratio
in ASD.
ASDs are highly heritable and genomic studies have
revealed that a substantial proportion of ASD risk resides
in rare variation of high effect, ranging from chromosome
abnormalities and copy number variation (CNV) to single
nucleotide variation (SNV). These studies have highlighted
a striking degree of genetic heterogeneity, implicating both
de novo germline mutation and rare inherited variation in
ASD distributed across numerous genes. De novo CNVs
are observed in 5%–10% of screened ASD cases, some of
which have proven to alter high-risk genes now tested for
in the medical diagnostic setting. Exome-sequencing stu-
dies estimated another ~6% contribution to ASD, and
an additional 5% conferred by rare inherited recessive or
X-linked loss-of-function SNV. A genetic overlap between
ASD and other neuropsychiatric conditions has also been
increasingly recognized.
Interestingly, CNV testing and exome-sequencing have
so far yielded mostly non-overlapping genes, which may
reflect different mutational mechanisms, though they
may still perturb connected biological pathways. While
numerous ASD genes have been recognized to date, they
only account for a small fraction of the overall estimated
heritability, consistent with predictions that there are
~1000 loci underlying ASD and that many causal genes
and risk variants remain to be identified.
Here, I will discuss our latest genomic experiments to
identify and characterize additional ASD risk genes, and to
identify the biological relationships and common pathways
they share. Our combined results suggest that rare variants
affecting ASD risk in the population collectively encom-
pass hundreds of genes some being influenced by the
gender of the mutation carrier. Despite significant hetero-
geneity, genes group in a relatively small number of inter-
connected functional networks, particularly related to
neuronal signalling/development, synapse function and
chromatin regulation. All of these findings, ultimately,
contribute to our understanding of the cellular pathways
involved in ASD, providing new diagnostic and therapeutic
targets.
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